# US 2023/0265474 A1 · Squalene hopene cyclase derivatives and use thereof for producing ambrox

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0265474 A1
- Document ID: US20230265474A1
- Status: Published application
- Kind: A1
- Application number: 18/043,818
- Filed: 2021-09-02
- Published: 2023-08-24
- Earliest claimed: 2020-09-02
- Assignees: International Flavors & Fragrances Inc.
- Applicants: International Flavors & Fragrances, Inc.
- Inventors: Lyndsey Jane Bannon; Daniel Fernando Andrade Ribeiro Dourado; David Andrew Lipscomb; Peter Brian Alexander McIntyre; Stefan Mix; Thomas Shaw Shaw Moody; Derek Quinn; Paul Daniel Jones; Anubhav P.S. Narula
- Web page: https://patentgrep.com/patent/US20230265474A1

## CPC

- C12P 17/04: containing a five-membered hetero ring, e.g. griseofulvin {, vitamin C}
- C12N 9/90: Isomerases (5.)
- C12P 5/007: {containing one or more isoprene units, i.e. terpenes (carotenes C12P23/00)}
- C12Y 504/99017: Squalene--hopene cyclase (5.4.99.17)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Y: ENZYMES

## Abstract

Variants of Squalene Hopene Cyclase (SHC) isolated from Gluconobacter morbifer are provided as is a method for using the variant G. morbifer SHC to biocatalytically convert homofarnesol to ambrox.

## Claims

### Claim 1

A recombinant vector comprising a nucleic acid molecule encoding a Squalene Hopene Cyclase (SHC) polypeptide having at least 90% sequence identity to SEQ ID NO:2 and including an amino acid alteration, relative to SEQ ID NO:2, at position 166, 222, 223, 226, 227, 242, 249, 504, 574, 640, 641, 676, 677, 682 or a combination thereof.

### Claim 2 (depends on 1)

The recombinant vector of claim 1, wherein the amino acid alteration comprises a synonymous amino acid at position 166, 249 or 574 or amino acid substitution at position 222, 223, 226, 227, 242, 504, 640, 641, 676, 677, or 682.

### Claim 3 (depends on 1)

The recombinant vector of claim 1, wherein the amino acid alteration comprises P166P, V222Q, V222R, K223S, E226V, D227T, S242R, R249R, R504C, A574A, L640G, P641S, M676L, M677E, S682R, or a combination thereof.

### Claim 4 (depends on 1)

The recombinant vector of claim 1, further comprising an amino acid substitution, relative to SEQ ID NO:2, at position 45, 46, 54, 86, 139, 142, 178, 184, 194, 239, 278, 326, 335, 386, 455, 460, 603, 623, 624, 656, 658, or a combination thereof.

### Claim 5 (depends on 4)

The recombinant vector of claim 4, wherein the amino acid substitution comprises V45I, V45Q, V45L, E46H, E46Q, Q54E, S86A, F139L, Y142R, Q178E, M184A, M184L, M184I, M184V, R194Q, G239V, I278V, T326S, L335F, E386Q, I455T, F460A, Q603H, G623A, G623V, F624Y, F624A, L656E, Y658F, or a combination thereof.

### Claim 6 (depends on 1)

A recombinant host cell comprising the recombinant vector of claim 1.

### Claim 7

A recombinant Squalene Hopene Cyclase (SHC) polypeptide having at least 90% sequence identity to SEQ ID NO:2 and including an amino acid alteration, relative to SEQ ID NO:2, at position 166, 222, 223, 226, 227, 242, 249, 504, 574, 640, 641, 676, 677, 682 or a combination thereof.

### Claim 8 (depends on 7)

The recombinant SHC of claim 7, wherein the amino acid alteration comprises a synonymous amino acid at position 166, 249 or 574 or amino acid substitution at position 222, 223, 226, 227, 242, 504, 640, 641, 676, 677, or 682.

### Claim 9 (depends on 7)

The recombinant SHC of claim 7, wherein the amino acid alteration comprises P166P, V222Q, V222R, K223S, E226V, D227T, S242R, R249R, R504C, A574A, L640G, P641S, M676L, M677E, S682R, or a combination thereof.

### Claim 10 (depends on 7)

The recombinant SHC of claim 7, further comprising an amino acid substitution, relative to SEQ ID NO:2, at position 45, 46, 54, 86, 139, 142, 178, 184, 194, 239, 278, 326, 335, 386, 455, 460, 603, 623, 624, 656, 658, or a combination thereof.

### Claim 11 (depends on 10)

The recombinant SHC of claim 10, wherein the amino acid substitution comprises V45I, V45Q, V45L, E46H, E46Q, Q54E, S86A, F139L, Y142R, Q178E, M184A, M184L, M184I, M184V, R194Q, G239V, I278V, T326S, L335F, E386Q, I455T, F460A, Q603H, G623A, G623V, F624Y, F624A, L656E, Y658F, or a combination thereof.

### Claim 12 (depends on 6)

A method for producing ambroxan comprising
(a) providing homofarnesol to the recombinant host cell of claim 6, and
(b) collecting ambroxan produced by the host cell.

### Claim 13 (depends on 12)

The method of claim 12, wherein the homofarnesol comprises (3E,7E) homofarnesol.
